tiprankstipranks
Advertisement
Advertisement
NovaBridge Biosciences Highlights 2025 Results and Advances Late-Stage Oncology and Ophthalmology Programs
PremiumCompany AnnouncementsNovaBridge Biosciences Highlights 2025 Results and Advances Late-Stage Oncology and Ophthalmology Programs
3M ago
IMAB Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
IMAB Upcoming Earnings Report: What to Expect?
3M ago
NovaBridge Wins FDA Backing for Accelerated Approval Pathway for Givastomig in Gastric Cancer
Premium
Company Announcements
NovaBridge Wins FDA Backing for Accelerated Approval Pathway for Givastomig in Gastric Cancer
4M ago
NovaBridge Biosciences Unveils February Investor Deck Detailing Global Hub-and-Spoke Biotech Strategy
PremiumCompany AnnouncementsNovaBridge Biosciences Unveils February Investor Deck Detailing Global Hub-and-Spoke Biotech Strategy
4M ago
NovaBridge appoints Cunningham as Vice Chairman of Board of Directors
Premium
The Fly
NovaBridge appoints Cunningham as Vice Chairman of Board of Directors
5M ago
NovaBridge Biosciences Names Emmett Cunningham Vice Chairman to Bolster Biotech Platform
Premium
Company Announcements
NovaBridge Biosciences Names Emmett Cunningham Vice Chairman to Bolster Biotech Platform
5M ago
Reaffirming Buy on NovaBridge Biosciences: Differentiated Givastomig Profile, Expanded Patient Reach, and Strengthened Long-Term Value Proposition
PremiumRatingsReaffirming Buy on NovaBridge Biosciences: Differentiated Givastomig Profile, Expanded Patient Reach, and Strengthened Long-Term Value Proposition
5M ago
NovaBridge resumed with a Buy at H.C. Wainwright
Premium
The Fly
NovaBridge resumed with a Buy at H.C. Wainwright
5M ago
NovaBridge CEO Begins Open-Market Purchases of Company ADSs
Premium
Company Announcements
NovaBridge CEO Begins Open-Market Purchases of Company ADSs
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100